A detailed history of New England Research & Management, Inc. transactions in Mckesson Corp stock. As of the latest transaction made, New England Research & Management, Inc. holds 1,415 shares of MCK stock, worth $723,942. This represents 0.4% of its overall portfolio holdings.

Number of Shares
1,415
Previous 1,550 8.71%
Holding current value
$723,942
Previous $832,000 0.72%
% of portfolio
0.4%
Previous 0.41%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$518.81 - $607.81 $70,039 - $82,054
-135 Reduced 8.71%
1,415 $826,000
Q1 2024

Apr 16, 2024

BUY
$473.42 - $539.26 $733,801 - $835,853
1,550 New
1,550 $832,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $73.5B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.